Literature DB >> 25426543

Cell reprogramming for skeletal dysplasia drug repositioning.

Peter Karagiannis1, Noriyuki Tsumaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25426543      PMCID： PMC4614517          DOI： 10.4161/15384101.2014.989944

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  iPS cells: a game changer for future medicine.

Authors:  Haruhisa Inoue; Naoki Nagata; Hiromi Kurokawa; Shinya Yamanaka
Journal:  EMBO J       Date:  2014-02-05       Impact factor: 11.598

2.  Statin treatment rescues FGFR3 skeletal dysplasia phenotypes.

Authors:  Akihiro Yamashita; Miho Morioka; Hiromi Kishi; Takeshi Kimura; Yasuhito Yahara; Minoru Okada; Kaori Fujita; Hideaki Sawai; Shiro Ikegawa; Noriyuki Tsumaki
Journal:  Nature       Date:  2014-09-17       Impact factor: 49.962

3.  Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice.

Authors:  Stéphanie Garcia; Béatrice Dirat; Thomas Tognacci; Nathalie Rochet; Xavier Mouska; Stéphanie Bonnafous; Stéphanie Patouraux; Albert Tran; Philippe Gual; Yannick Le Marchand-Brustel; Isabelle Gennero; Elvire Gouze
Journal:  Sci Transl Med       Date:  2013-09-18       Impact factor: 17.956

4.  Protective effect of atorvastatin in cultured osteoarthritic chondrocytes.

Authors:  Theodora Simopoulou; Konstantinos N Malizos; Lazaros Poultsides; Aspasia Tsezou
Journal:  J Orthop Res       Date:  2010-01       Impact factor: 3.494

Review 5.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Authors:  Jonathan A Tobert
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

6.  Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway.

Authors:  Akihiro Yasoda; Yasato Komatsu; Hideki Chusho; Takashi Miyazawa; Ami Ozasa; Masako Miura; Tatsuya Kurihara; Tomohiro Rogi; Shoji Tanaka; Michio Suda; Naohisa Tamura; Yoshihiro Ogawa; Kazuwa Nakao
Journal:  Nat Med       Date:  2003-12-14       Impact factor: 53.440
  6 in total
  1 in total

Review 1.  Human induced pluripotent stem cells for monogenic disease modelling and therapy.

Authors:  Paola Spitalieri; Valentina Rosa Talarico; Michela Murdocca; Giuseppe Novelli; Federica Sangiuolo
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.